EIF2AK3 and pancreatic neoplasm: Recently, Yang et al. reported that anlotinib can directly inhibit the proliferation of and induce apoptosis in pancreatic cancer cells through ROS-activated ER stress via PERK/p-eIF2α/ATF4 (Yang L. et al., 2020).